![headshot](https://opd-resources.mcw.edu/FileLibrary/OPD/Providers/photos/FieldJosh10-2022.jpg?w=400&h=450&mode=crop&anchor=middlecenter&scale=both 400w)
Joshua J. Field, MD, MS
Professor
Locations
- Froedtert Hospital
- Children's Wisconsin - Milwaukee
- Children's Wisconsin Clinics - Milwaukee
- Cancer Center - Moorland Reserve Health Center
Specialties
- Hematology
Languages
- English
Established Patient Appointments
Moorland Reserve Health Center
New Patient Appointments
Sickle Cell Clinic
Education
- MD - Doctor of Medicine
- MS
Biography
Dr. Joshua Field is an Associate Professor of Medicine in the Division of Hematology and Oncology at the Medical College of Wisconsin. He is also serving as Section Chief of Benign Hematology and Medical Director of the Sickle Cell Clinic in the Froedtert Hospital. Dr. Field specializes in the treatment of sickle cell disease and other benign hematological disorders at Froedtert Hospital Dr. Field graduated medical school from the University of Iowa. He completed an internal medicine residency and fellowships in hematology and transfusion medicine at Washington University in St. Louis, where he was chief resident in internal medicine and chief fellow in hematology and oncology.
Dr. Field is also serving as Senior Medical Director and Senior Investigator in Versiti.
Research Interests
Publications
-
(Singh A, Brousseau DC, Dasgupta M, Shet AS, Field JJ, Brandow AM.) PLoS One. 2024;19(4):e0297469 PMID: 38626063 PMCID: PMC11020686 SCOPUS ID: 2-s2.0-85190748125 04/16/2024
-
(Mucalo L, Field JJ, Highland J, Khan H, Hankins JS, Singh A, Brandow AM.) Blood Adv. 2023 Jul 25;7(14):3658-3665 PMID: 37058480 PMCID: PMC10365933 SCOPUS ID: 2-s2.0-85183192690 04/15/2023
-
(Singh A, Sontag MK, Zhou M, Dasgupta M, Crume T, McLemore M, Galadanci N, Randall E, Steiner N, Brandow AM, Koch K, Field JJ, Hassell K, Snyder AB, Kanter J.) JMIR Public Health Surveill. 2023 Jun 28;9:e42816 PMID: 37379070 PMCID: PMC10365593 SCOPUS ID: 2-s2.0-85163580848 06/28/2023
-
Secondary Neoplasms After Hematopoietic Cell Transplant for Sickle Cell Disease.
(Eapen M, Brazauskas R, Williams DA, Walters MC, St Martin A, Jacobs BL, Antin JH, Bona K, Chaudhury S, Coleman-Cowger VH, DiFronzo NL, Esrick EB, Field JJ, Fitzhugh CD, Kanter J, Kapoor N, Kohn DB, Krishnamurti L, London WB, Pulsipher MA, Talib S, Thompson AA, Waller EK, Wun T, Horowitz MM.) J Clin Oncol. 2023 Apr 20;41(12):2227-2237 PMID: 36623245 PMCID: PMC10448940 SCOPUS ID: 2-s2.0-85152619905 01/10/2023
-
(Gunderson SJ, Snowden N, Field JJ.) Hematol Rep. 2023 Feb 03;15(1):101-107 PMID: 36810554 PMCID: PMC9944850 02/23/2023
-
(Karafin MS, Field JJ, Ilich A, Li L, Qaquish BF, Shevkoplyas SS, Yoshida T.) Transfusion. 2023 Jan;63(1):193-202 PMID: 36310401 SCOPUS ID: 2-s2.0-85141155772 11/01/2022
-
(Kuter DJ, Rogers KA, Boxer MA, Choi M, Agajanian R, Arnold DM, Broome CM, Field JJ, Murakhovskaya I, Numerof R, Tong S.) Am J Hematol. 2022 Jun 01;97(6):691-699 PMID: 35179251 PMCID: PMC9313871 SCOPUS ID: 2-s2.0-85125529424 02/19/2022
-
(Wilson SR, Sears M, Williams E, Drapekin J, Sivakumar I, Padrino S, Desai PC, Hager W, Manwani D, Clay LJ, Field JJ, Kanter J, Cohen AJ, Saif Ur Rehman S, Lanzkron S, Little JA, GRNDaD investigators.) Br J Haematol. 2021 Dec;195(5):e157-e160 PMID: 34423416 SCOPUS ID: 2-s2.0-85113314912 08/24/2021
-
(Lanzkron S, Little J, Wang H, Field JJ, Shows JR, Haywood C Jr, Saheed M, Proudford M, Robertson D, Kincaid A, Burgess L, Green C, Seufert R, Brooks J, Piehet A, Griffin B, Arnold N, Frymark S, Wallace M, Abu Al Hamayel N, Huang CY, Segal JB, Varadhan R.) Ann Intern Med. 2021 Sep;174(9):1207-1213 PMID: 34224261 SCOPUS ID: 2-s2.0-85117425920 07/06/2021
-
(Karafin MS, Simpson P, Field JJ.) Acta Haematol. 2021;144(1):111-116 PMID: 32403100 SCOPUS ID: 2-s2.0-85085034465 05/14/2020
-
Circulating fibrocytes as prognostic biomarkers of autoimmune interstitial lung disease.
(Odackal J, Yu V, Gomez-Manjerres D, Field JJ, Burdick MD, Mehrad B.) ERJ Open Res. 2020 Oct;6(4) PMID: 33263049 PMCID: PMC7682700 12/03/2020
-
Phase 2 trial of montelukast for prevention of pain in sickle cell disease.
(Field JJ, Kassim A, Brandow A, Embury SH, Matsui N, Wilkerson K, Bryant V, Zhang L, Simpson P, DeBaun MR.) Blood Adv. 2020 Mar 24;4(6):1159-1165 PMID: 32208487 PMCID: PMC7094028 SCOPUS ID: 2-s2.0-85082514389 03/26/2020